Immunosuppressive therapy is the treatment for aplastic anemia patients ineligible for
transplantation. The role of hematopoietic growth factors as adjunct to treatment in these …

Severe aplastic anemia (SAA) is a rare potentially fatal hematologic disorder. Although
overall outcomes with treatment are excellent, there are variations in management …

Rabbit antithymocyte globulin (rATG) was proven effective as salvage therapy for refractory
aplastic anemia (AA), or for relapse after initial therapy with horse ATG (hATG). Several …

Objectives Antithymocyte globulin (ATG)‐based immunosuppression remains a cornerstone
in aplastic anaemia (AA) treatment. However, most ATG studies are not population‐based …

Purpose Acquired aplastic anemia is an organ-specific auto-immune disease characterized
by pancytopenia and hypoplastic bone marrow. Immunosuppression with anti-thymocyte …

Aplastic anemia is a rare and heterogeneous disease that causes pancytopenia and aplasia
of the bone marrow. It is characterized by a failure of hematopoiesis. It is believed that …

We report on a 22-year-old female who developed aplastic anemia after administration of
phenobarbital for 6 years. Being refractory to steroid and anti-lymphocyte serum, the patient …

A 61-year-old Japanese man was referred to our hospital in 2002 due to severe
pancytopenia. Bone marrow and peripheral blood findings indicated he had severe aplastic …

目的分析环孢霉素A (CsA) 单药治疗的非重型再生障碍性贫血(NSAA) 患者获得疗效后,
影响复发的因素. 方法回顾性收集2012 年10 月—2020 年11 月在北京协和医院就诊并采用标准 …